Margins matter. The more Exactech (NAS: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

Margins matter. The more Exactech (NAS: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

GAINESVILLE, Fla., Feb. 18, 2025 /PRNewswire/ — Exactech, a global leader in medical technology, presented 15 new studies describing new research and advancements in total joint arthroplasty and ...

Margins matter. The more Exactech (Nasdaq: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

In March, Exactech told customers it would recall shoulder devices to “eliminate confusion and concern in the market” following the FDA’s safety warning. Exactech began recalling some devices in 2021 ...

Medical devicemaker Exactech agreed to pay $8 million to settle allegations that it knowingly marketed and sold defective components within its line of Optetrak total knee systems, which have been ...

Margins matter. The more Exactech (Nasdaq: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Exactech, which is owned by private equity firm TPG, entered bankruptcy with $352 million in debt and a sale agreement that would turn over the company's assets to its lenders. The sale agreement is ...

Exactech Inc. (Nasdaq: EXAC) has agreed to acquire Altiva Corp., a Charlotte, N.C.-based maker of spinal implant devices and related products. The deal represents Exactech's decision to exercise a ...